ULISSE BIOMED SPA (UBM.MI) Stock Income Statement
BIT:UBM - Euronext Milan - IT0005451213 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 767.90K | 66.20K | 138.40K | 276.60K | 428.60K | |||
| Cost Of Goods | 1.80M | 1.62M | 1.03M | 545.90K | 228.20K | |||
| Gross Profit | -1.03M | -1.55M | -894.80K | -269.20K | 200.40K | |||
| Operating Expenses | 4.87M | 923.20K | 411.60K | 334.20K | -23.80K | |||
| Selling, General, and Administrative Expenses | 1.81M | 497.30K | 330.00K | 140.80K | 111.30K | |||
| Operating Income | -5.90M | -2.47M | -1.31M | -603.40K | 224.20K | |||
| Interest Income/Expense | -35.10K | -300.00 | -1.40K | -400.00 | -100.00 | |||
| Other Income/Expense | N/A | N/A | 100.00 | 200.00 | 0.00 | |||
| Income Before Taxes | -5.94M | -2.47M | -1.31M | -603.60K | 224.20K | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 2.30K | |||
| Net Income | -5.94M | -2.47M | -1.31M | -603.60K | 221.80K | |||
| EBITDA | -2.98M | -2.14M | -986.80K | -355.70K | 275.10K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.27 | -0.30 | -0.16 | -0.07 | 0.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | -134.78% | -2340.03% | -646.53% | -97.32% | 46.76% | |||
| Profit Margin | -773.51% | -3735.05% | -944.94% | -218.22% | 51.75% | |||
| Operating Profit Margin | -768.95% | -3734.59% | -943.93% | -218.15% | 52.31% | |||
All data in EUR